Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

UNITED STATES: Pfizer's Drug to Treat Tuberculosis in Short Supply


Reuters (03.25.13)

In an online post on March 25, the Food and Drug Administration (FDA) reported that it has added the injectable antibiotic rifampin, manufactured by Pfizer, Inc., to the list of drugs that are currently in short supply. The shortage of the drug used for TB treatment is expected to last until June and is being caused by a manufacturing delay. Although TB rates are at an all-time low in the United States, the shortage comes at a time when prevalence of the disease is increasing globally. In correspondence addressed to physicians on March 18, the drug manufacturer wrote that some vials of the medication may not meet specifications for drug potency, and had exhibited a change in hue from the expected red powder to brown or black. Pfizer stated that it was investigating the matter. According to CDC, in 2011 approximately 9 million individuals globally became infected with TB, and there were 1.4 million TB-related fatalities.


Copyright © 2013 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in March 27, 2013. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.